NFL Biosciences SA (ALNFL.PA) Comparison with companies in other sectors?

NFL Biosciences SA has a share price of 12.61M. You can analyze NFL Biosciences SA (ALNFL.PA) competitors across different market sectors through stock heatmaps.

What are ALNFL.PA's NET and operating margins?

NFL Biosciences SA (ALNFL.PA) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does ALNFL.PA's earnings per share (EPS) trend reflect its financial momentum?

NFL Biosciences SA (ALNFL.PA) EPS is -0.21 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for NFL Biosciences SA is -6.08, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for NFL Biosciences SA?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for NFL Biosciences SA like P/E which is -6.03, P/B which is 12.85, and PEG which is -0.28. Compare them with sector averages to evaluate if the stock is priced fairly.

NFL Biosciences SA

ALNFL.PA•EURONEXT

Healthcare

Biotechnology

€1.28

€0.08(6.84%)

Fundamental Analysis of NFL Biosciences SA (ALNFL.PA)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.21

P/E Ratio

-6.08

ROE

-1.27%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$16.10M

Shares OutstandingTotal number of shares issued

$12.61M

Book Value/ShareNet worth per share

$0.10

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.21

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

-127.48%

ROAReturn on total assets

-57.64%

ROCEReturn on capital employed

-285.74%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$0.21

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for ALNFL.PAFinancial Ratios Analysis details for ALNFL.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ALNFL.PASector Benchmarking details for ALNFL.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for NFL Biosciences SA Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of NFL Biosciences SA. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account NFL Biosciences SA's unique business strengths and challenges.

Key Financial Metrics for NFL Biosciences SA

For NFL Biosciences SA, essential financial indicators include EPS -0.21, PE -6.08, and ROE -1.27. These key ratios reveal insights into NFL Biosciences SA's profitability, valuation, and operational health. Understanding these metrics enables you to compare NFL Biosciences SA with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of NFL Biosciences SA

Metrics like Net Margin - and ROA -57.64% shed light on how well NFL Biosciences SA is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether NFL Biosciences SA can sustain its operations and continue growing in the future.

Valuation and Market Position of NFL Biosciences SA

Using ratios such as P/B Ratio 12.85 and PEG Ratio -0.28, investors can assess whether NFL Biosciences SA is appropriately valued based on its financials and growth potential. These figures, combined with NFL Biosciences SA's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for NFL Biosciences SA

Financial health indicators, such as Debt/Equity Ratio 0.04 and Cash Flow -, provide a snapshot of NFL Biosciences SA's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like NFL Biosciences SA, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for NFL Biosciences SA

Investing in NFL Biosciences SA based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at NFL Biosciences SA focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;